Abstract
HI, a fusion protein that consists of the alpha-toxin (Hla) and the N2 domain of iron surface determinant B (IsdB), is one of the antigens in the previously reported S. aureus vaccine rFSAV and has already entered phase II clinical trials. Previous studies revealed that HI is highly immunogenic in both mice and healthy volunteers, and the humoral immune response plays key roles in HI-mediated protection. In this study, we further investigated the protective efficacy of immunization with HI plus four different adjuvants in a mouse bacteremia model. Results showed that HI-mediated protection was altered in response to different adjuvants. Using antisera from immunized mice, we identified seven B-cell immunodominant epitopes on Hla and IsdB, including 6 novel epitopes (Hla1-18, Hla84-101, Hla186-203, IsdB342-359, IsdB366-383, and IsdB384-401). The immunodominance of B-cell epitopes, total IgG titers and the levels of IFN-γ and IL-17A from mice immunized with HI plus different adjuvants were different from each other, which may explain the difference in protective immunity observed in each immunized group. Thus, our results indicate that adjuvants largely affected the immunodominance of epitopes and the protective efficacy of HI, w...Continue Reading
References
Oct 24, 2000·Journal of Immunological Methods·L E DeForgeS M Kramer
Mar 26, 2004·Vaccine·Ali I FattomRobert Naso
Nov 1, 2007·Clinical Pharmacology and Therapeutics·D T O'HaganA Podda
May 16, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Satish L DeshmaneBassel E Sawaya
Apr 7, 2010·The Journal of Clinical Investigation·John S ChoLloyd S Miller
Feb 1, 2011·Protein Science : a Publication of the Protein Society·Yoshikazu TanakaIsao Tanaka
May 18, 2011·Biochemistry·Catherine F M GaudinMichael E P Murphy
Dec 24, 2011·Vaccine·Clayton D HarroNicholas A Kartsonis
Jan 27, 2012·The Journal of Infectious Diseases·Chahnaz KebaierJoseph A Duncan
Jul 18, 2012·Infection and Immunity·Sabine RauchOlaf Schneewind
Jan 3, 2013·Cellular Microbiology·Marta ZapotocznaTimothy J Foster
May 31, 2013·Frontiers in Immunology·Sunita AwateGeorge Mutwiri
Dec 11, 2013·PloS One·Qian-Fei ZuoQuan-Ming Zou
Nov 5, 2014·Medical Mycology·Deivys Leandro F PortuondoIracilda Z Carlos
Nov 14, 2014·Journal of Clinical Microbiology·Batu K Sharma-KuinkelMark T Esser
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Ali FattomDominique Boutriau
May 29, 2015·Clinical Microbiology Reviews·Steven Y C TongVance G Fowler
Oct 23, 2015·Scientific Reports·Jinyong ZhangHao Zeng
Nov 3, 2016·PloS One·Kam Leng Aw-YongYoke Fun Chan
Dec 6, 2016·Vaccine·Robert W FrenckDouglas Girgenti
Oct 11, 2017·Frontiers in Immunology·Denicar Lina Nascimento Fabris MaedaJuliana Falcão Rodrigues
Nov 18, 2017·Vaccine·Milene Tavares BatistaRita de Cássia Café Ferreira
Feb 6, 2018·Hospital Practice·Jessica K Ortwine, Kavita Bhavan
Feb 22, 2018·Perspectives in Public Health·Asokan Govindaraj Vaithinathan, A Vanitha
Feb 28, 2018·Scientific Reports·Wei YuYudong Cui
Mar 12, 2018·Molecular Immunology·Ehsan ChoubiniSaeid Bouzari
May 29, 2018·Seminars in Immunology·Giuseppe Del GiudiceArnaud M Didierlaurent
Oct 22, 2018·Intensive Care Medicine·Bruno FrançoisUNKNOWN MASTER 1 study group
Mar 8, 2019·MMWR. Morbidity and Mortality Weekly Report·Athena P KourtisDenise Cardo
May 3, 2019·Vaccine·Shuting ShiBingbing Sun
Jul 20, 2019·Vaccine·Julia VolckmarDunja Bruder
Sep 19, 2019·Computational and Structural Biotechnology Journal·Carmen MeiMarina Kirkitadze
Nov 14, 2019·Vaccines·Xinyi WangChuanlai Shen
Dec 25, 2019·Microbial Pathogenesis·Seyedeh Shadi MortazaviMehdi Mahdavi
Mar 22, 2020·Vaccines·Hao ZengQuanming Zou
Sep 23, 2020·The Journal of Infectious Diseases·Hao ZengZhuo Zhao